2025 CiteScore: 0.3
The Journal is now indexed by Scopus.
The Journal of Orthopedic and Spine Trauma (JOST) is a peer-reviewed, open-access journal dedicated to publishing high-quality scientific, clinical, translational, educational, and methodological research in orthopedic surgery, spine surgery, trauma, and related musculoskeletal fields.
Authors are strongly advised to read these guidelines carefully before submitting a manuscript. Manuscripts that do not comply with the journal’s requirements may be returned to the authors before peer review.
JOST welcomes manuscripts from orthopedic surgeons, spine surgeons, trauma surgeons, sports medicine specialists, rehabilitation specialists, musculoskeletal researchers, radiologists, physiotherapists, residents, fellows, and multidisciplinary research teams.
The journal considers manuscripts in the fields of orthopedic trauma, spine trauma, spine surgery, arthroplasty, sports medicine, arthroscopy, pediatric orthopedics, hand and upper extremity surgery, foot and ankle surgery, hip and knee surgery, shoulder and elbow surgery, musculoskeletal oncology, osteoporosis, fracture healing, nonunion, infection, rehabilitation, biomechanics, musculoskeletal imaging, surgical education, research methodology, artificial intelligence, and digital health in orthopedic and spine research.
All manuscripts must be submitted through the journal’s online submission system.
Authors should select the most appropriate article type at the time of submission. The Editorial Board reserves the right to reclassify the manuscript type during editorial assessment.
|
Article Type |
Abstract |
Word Limit |
Reference Limit |
Figure/Table Limit |
Reporting Checklist |
|
Original Article |
Structured: Background, Methods, Results, Conclusion |
3,500–4,000 |
50–60 |
Up to 6 |
STROBE for observational studies; CONSORT for randomized clinical trials |
|
Brief Report / Short Communication |
Structured |
1,500–2,000 |
20–25 |
Up to 3 |
STROBE for observational studies; CONSORT for randomized clinical trials |
|
Review Article / Narrative Review |
Structured, semi-structured, or unstructured |
4,000–5,000 |
80–100 |
Up to 6 |
Not routinely required |
|
Systematic Review / Meta-analysis |
Structured + PRISMA flow diagram |
4,000–5,000 |
100–120 |
6–8 |
PRISMA |
|
Case Report |
Semi-structured: Background, Case Presentation, Conclusion |
1,500–2,000 |
15–20 |
Up to 4 |
CARE |
|
Case Series |
Structured: Background, Methods/Cases, Results, Conclusion |
2,000–3,000 |
20–30 |
Up to 5 |
PROCESS for surgical case series; CARE when applicable |
|
Technical Note / Surgical Technique |
Unstructured or semi-structured |
1,500–2,500 |
10–15 |
Up to 4 |
PROCESS and/or TIDieR when applicable |
|
Case-Based Expert Review |
Structured or narrative |
2,500–3,500 |
25–40 |
Up to 5 |
Not routinely required |
|
Educational Corner |
Structured or narrative |
2,000–3,000 |
15–30 |
3–4 |
Not routinely required |
|
Letter to the Editor |
No abstract or short optional abstract |
500–800 |
5–10 |
Up to 1 |
Not applicable |
|
Editorial / Commentary |
No abstract or short optional abstract |
800–1,500 |
5–15 |
Up to 1 |
Not applicable |
*Word limits refer to the main text and generally exclude abstract, references, tables, and figure legends unless otherwise specified.
Manuscripts must be written in clear, concise, and grammatically correct English. Authors whose first language is not English are strongly encouraged to have the manuscript reviewed by a professional English editor or fluent scientific English speaker before submission.
Authors should avoid unnecessary jargon, excessive abbreviations, unsupported claims, and promotional language.
Manuscripts should be prepared using Microsoft Word or a compatible word-processing format.
The main manuscript should be formatted as follows:
To support double-anonymous peer review, authors must submit both a Title Page and a Blinded Main Manuscript.
Authors should upload the following files when applicable:
The title page should be uploaded as a separate file and should include:
The title should be concise, informative, and specific. Titles should avoid unnecessary abbreviations and should not overstate the findings.
The blinded manuscript should not contain information that directly identifies the authors or their institutions.
Authors should remove:
When the removal of institutional information is not possible because it is essential to the study's interpretation, authors should minimize identifiable details. The Editorial Office will determine whether the manuscript can proceed under double-anonymous peer review.
For Original Articles, the manuscript should generally be arranged as follows:
Other article types should follow the structure described in the Article Types section.
Original Articles, Brief Reports, Systematic Reviews, Meta-analyses, Case Series, and most observational studies should include a structured abstract.
For Original Articles, the abstract should include:
Background: Clinical or scientific context and study objective.
Methods: Study design, setting, participants, interventions or exposures, outcome measures, and statistical approach.
Results: Main findings with relevant numerical results, confidence intervals, and P values where appropriate.
Conclusion: Main interpretation and clinical or scientific implication.
For Case Reports, a semi-structured abstract may include:
Background, Case Presentation, Conclusion
For Narrative Reviews, Commentaries, Editorials, and Educational Corner articles, an unstructured or semi-structured abstract may be acceptable.
Abstracts should be concise and should not include references, undefined abbreviations, or claims not supported by the manuscript.
Authors should provide 3 to 6 keywords. Keywords should preferably be selected from Medical Subject Headings (MeSH), when applicable.
Keywords should be specific and relevant to the manuscript. General terms such as “orthopedics,” “surgery,” or “trauma” should be avoided unless they are central to the manuscript.
The Introduction should provide the clinical or scientific background, identify the knowledge gap, and state the study objective or hypothesis.
The Introduction should be concise and should not include an extensive review of the literature.
The Methods section should provide sufficient detail to allow assessment and replication of the study.
Depending on study design, the Methods section should include:
For surgical studies, authors should clearly describe the surgical indication, approach, technique, implant or device, perioperative care, rehabilitation protocol, complications, and follow-up duration.
For imaging-based studies, authors should specify imaging modality, acquisition protocol when relevant, reader expertise, measurement methods, reliability assessment, and diagnostic thresholds when applicable.
The Results section should present findings clearly and objectively without interpretation.
Authors should report:
Results should be consistent with the Methods section and should not introduce analyses that were not described in the Methods.
The Discussion should interpret the findings in relation to the study objective and existing literature.
The Discussion should generally include:
Authors should avoid unsupported conclusions, exaggerated clinical claims, or statements implying causality when the study design does not support causal inference.
The Conclusion should be brief and directly supported by the study findings. It should not repeat the abstract or overstate the importance of the results.
JOST requires authors to follow internationally accepted reporting guidelines according to the design and methodology of their study.
Completed checklists should be uploaded as supplementary files during submission. Each checklist must include manuscript page numbers showing where each required item is addressed.
|
Study Type |
Required Guideline |
Required File at Submission |
|
Randomized clinical trial |
CONSORT |
Completed CONSORT checklist + flow diagram https://www.equator-network.org/reporting-guidelines/consort/?utm_source=chatgpt.com |
|
Clinical trial protocol |
SPIRIT |
Completed SPIRIT checklist |
|
Observational study: cohort, case-control, cross-sectional |
STROBE |
Completed STROBE checklist |
|
Systematic review/meta-analysis |
PRISMA |
Completed PRISMA checklist + flow diagram |
|
Scoping review |
PRISMA-ScR |
Completed PRISMA-ScR checklist |
|
Diagnostic accuracy study |
STARD |
Completed STARD checklist |
|
Case report |
CARE |
Completed CARE checklist |
|
Surgical case report |
SCARE |
Completed SCARE checklist |
|
Surgical case series |
PROCESS |
Completed PROCESS checklist |
|
Prediction model/machine learning / artificial intelligence |
TRIPOD+AI |
Completed TRIPOD+AI checklist |
|
Animal / in vivo experimental study |
ARRIVE 2.0 |
Completed ARRIVE checklist |
|
Surgical, rehabilitation, device, implant, injection, or therapeutic intervention |
TIDieR, in addition to the main study-design guideline |
Completed TIDieR checklist when applicable |
|
Quality improvement study |
SQUIRE |
Completed SQUIRE checklist when applicable |
Manuscripts submitted without the required checklist may be returned to the authors before peer review.
All studies involving human participants, human tissue, human data, medical records, clinical images, radiographs, CT, MRI, surgical photographs, or other patient-related material must have been reviewed and approved by an appropriate ethics committee or institutional review board.
The manuscript must include a clear ethics statement in the Methods section and in the Declarations section. The statement should include the name of the approving ethics committee, approval code or reference number, and date of approval when available.
Example:
Ethics Approval:
This study was approved by the Ethics Committee of [Institution Name] under approval number [Approval Code]. The study was conducted in accordance with the Declaration of Helsinki and relevant institutional guidelines.
If ethics approval was waived or deemed unnecessary, authors must state the name of the committee or authority that granted the waiver and provide the reason.
For prospective studies involving human participants, authors must obtain informed consent unless the requirement has been formally waived by an appropriate ethics committee.
Example:
Consent to Participate:
Written informed consent was obtained from all participants before enrollment.
For retrospective studies, authors should state whether informed consent was obtained or waived by the relevant ethics committee.
Written consent for publication is required when a manuscript includes potentially identifiable patient information, clinical photographs, intraoperative images, radiographs, imaging studies, pedigrees, or case details that may allow identification of the patient.
Example:
Consent for Publication:
Written informed consent for publication of clinical details and images was obtained from the patient.
If the patient is deceased, a minor, or unable to provide consent, consent must be obtained from the legal guardian or next of kin, according to applicable regulations.
JOST requires prospective registration of clinical trials in a publicly accessible clinical trial registry before enrollment of the first participant.
A clinical trial is defined as any research study that prospectively assigns human participants or groups of participants to one or more health-related interventions to evaluate the effects on health outcomes. This includes, but is not limited to, surgical procedures, implants, devices, rehabilitation protocols, injections, medications, behavioral interventions, educational interventions, and process-of-care changes.
The trial registration number and registry name must be included in the abstract and Methods section.
Example:
Trial Registration:
This clinical trial was registered at [Registry Name] under registration number [Registration Number] before enrollment of the first participant.
Retrospective registration is generally not acceptable. In exceptional circumstances, the authors must explain why prospective registration was not performed. The Editorial Board will determine whether the manuscript can proceed to peer review.
All manuscripts should include a Declarations section before the References.
The following items should be included:
If an item is not applicable, authors should state “Not applicable.”
All manuscripts reporting original research must include a Data Availability Statement.
Examples:
Data Availability:
The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Data Availability:
The data are not publicly available due to patient privacy and ethical restrictions but may be made available from the corresponding author upon reasonable request and with appropriate institutional approval.
Data Availability:
All data generated or analyzed during this study are included in this published article and its supplementary files.
For clinical trials, authors should include a data sharing statement when applicable.
Authorship should be based on substantial intellectual contribution, responsibility, and accountability.
All authors must meet all of the following criteria:
Individuals who contributed to the work but do not meet all authorship criteria should be acknowledged rather than listed as authors.
All manuscripts must include an Author Contributions statement. JOST encourages use of the CRediT taxonomy when applicable.
Example:
Author Contributions:
Conceptualization: AA, BB. Methodology: AA, CC. Data collection: DD, EE. Formal analysis: CC. Writing—original draft: AA. Writing—review and editing: BB, CC, DD. Supervision: BB. All authors read and approved the final manuscript.
Any change in authorship after submission requires a written explanation and signed approval from all authors, including any author being added or removed.
All authors must disclose any financial or non-financial relationships, activities, or interests that could influence or be perceived to influence the submitted work.
Potential conflicts include:
If there are no conflicts of interest, authors should state:
Conflict of Interest:
The authors declare that they have no conflicts of interest.
All sources of financial and material support must be disclosed, including grants, institutional funding, industry support, equipment, implants, devices, drugs, writing assistance, or statistical support.
Authors must also describe the role of the funder or sponsor in study design, data collection, analysis, interpretation, manuscript preparation, and the decision to submit for publication.
Example:
Funding:
This study received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Example:
Funding:
This study was supported by [Funder Name] under grant number [Grant Number]. The funder had no role in study design, data collection, analysis, interpretation, manuscript writing, or the decision to submit the article for publication.
Authors must disclose whether artificial intelligence-assisted tools were used in the preparation of the manuscript, including tools used for writing, language editing, data analysis, image generation, figure preparation, coding, reference handling, or statistical support.
AI tools, chatbots, large language models, and image generators cannot be listed as authors because they cannot take responsibility for the accuracy, integrity, originality, and accountability required for authorship.
Authors remain fully responsible for all content generated or assisted by AI tools, including accuracy, originality, plagiarism, fabricated references, biased statements, data integrity, and image integrity.
Example:
AI Use Statement:
The authors used [Name of AI Tool] for language editing and grammar improvement. The authors reviewed and edited the output and take full responsibility for the content of the manuscript.
If no AI was used:
AI Use Statement:
No AI-assisted tools were used in the preparation of this manuscript.
The use of AI to fabricate data, generate fake images, manipulate images without disclosure, create false references, or misrepresent scientific findings is strictly prohibited.
Tables should be prepared in an editable format, preferably using the table function in Microsoft Word. Tables should not be submitted as images.
Each table should include:
Tables should be numbered consecutively according to their first citation in the manuscript.
Statistical data should be reported clearly and consistently. Authors should report mean and standard deviation for normally distributed continuous variables, median and interquartile range for non-normally distributed variables, and number and percentage for categorical variables.
Figures should be numbered consecutively according to their first citation in the manuscript.
Each figure should have a complete legend explaining all relevant findings, symbols, arrows, abbreviations, and panels.
Acceptable figure formats include TIFF, JPEG, PNG, EPS, or PDF.
Recommended minimum resolution:
Clinical photographs, intraoperative images, radiographs, CT, MRI, ultrasound images, and other patient-related visual materials must be anonymized before submission.
Authors must remove:
If a patient can be identified from an image or clinical detail, written consent for publication must be obtained.
Authors must not alter images in a way that changes scientific meaning. Adjustments to brightness, contrast, or color are acceptable only when applied to the entire image and when they do not obscure or misrepresent findings.
Supplementary material may include additional information that supports the manuscript but is not essential to include in the main text.
Examples include:
Supplementary material should be cited in the main manuscript and clearly labeled.
Examples:
Supplementary Table 1
Supplementary Figure 1
Supplementary Video 1
Supplementary File 1
JOST may consider video files as supplementary material for manuscripts involving surgical techniques, rehabilitation protocols, gait analysis, procedural demonstrations, imaging interpretation, or educational content.
Videos should be anonymized and should not include identifiable patient information unless written consent for publication has been obtained.
Videos should be concise and should directly support the manuscript.
JOST uses the Vancouver reference style.
References should be numbered consecutively in the order in which they are first cited in the manuscript. Each reference should be assigned one number only. If the same source is cited again later, the original reference number should be used.
References should appear in the reference list in numerical order.
Authors should ensure that:
References should be cited in the text using Arabic numerals in parentheses.
Example:
Femoral neck fractures in elderly patients are associated with high morbidity and mortality (1).
When citing more than one reference, separate numbers with commas.
Example:
Several studies have evaluated surgical outcomes after lumbar decompression (2,3,5).
For a range of consecutive references, use a hyphen.
Example:
Different fixation methods have been described for calcaneal fractures (4-7).
Author(s). Title of article. Abbreviated Journal Title. Year; Volume (Issue): Page range. doi: DOI.
Example:
Smith AB, Jones CD, Brown EF. Clinical outcomes after operative treatment of distal radius fractures. J Orthop Trauma. 2022;36(4):210-216. doi:10.xxxx/xxxxx
For references with more than six authors, list the first six authors followed by “et al.”
A cover letter should be submitted with the manuscript.
The cover letter should include:
When submitting a revised manuscript, authors should upload:
The response letter should address each comment individually. Authors should indicate where changes were made in the manuscript.
If authors disagree with a comment, they should provide a polite and evidence-based explanation.
JOST uses a double-anonymous peer review process. The identities of authors are concealed from reviewers, and the identities of reviewers are concealed from authors.
All submitted manuscripts undergo initial editorial screening. Manuscripts may be rejected without external peer review if they are outside the scope of the journal, scientifically or methodologically unsuitable, ethically problematic, incomplete, duplicative, lacking sufficient novelty or relevance, or not prepared according to the journal’s requirements.
Manuscripts that pass initial editorial screening are sent to at least two independent expert reviewers. Additional statistical, methodological, or subspecialty reviewers may be invited when required.
Final editorial decisions are based on scientific quality, originality, methodological rigor, ethical integrity, relevance to the journal’s aims and scope, peer reviewer comments, and editorial judgment.
Possible editorial decisions include:
Submitted manuscripts must be original and must not be under consideration elsewhere.
Plagiarism, self-plagiarism, duplicate publication, salami publication, fabricated data, falsified data, image manipulation, undisclosed conflicts of interest, fake peer review, and inappropriate authorship practices are not acceptable.
JOST may use plagiarism detection software and may investigate suspected misconduct before or after publication.
When concerns arise, the Editorial Board may request explanations, raw data, ethics documents, patient consent documentation, image files, or institutional investigation.
Possible editorial actions include rejection, correction, expression of concern, retraction, notification of authors’ institutions, or other appropriate actions.
JOST is an open-access journal. All articles published in the journal are made freely available online immediately upon publication.
JOST does not charge authors any article processing charge. There are no submission fees, editorial processing fees, article processing charges, publication fees, page charges, color figure charges, or online publication charges.
The absence of publication fees does not influence editorial decisions. Manuscripts are evaluated based on scientific quality, originality, methodological soundness, ethical integrity, relevance to the journal’s aims and scope, and peer review.
Before submission, authors should ensure that:
For questions about manuscript suitability, article type, submission requirements, technical problems, or publication ethics, authors may contact the JOST Editorial Office.
Authors should use the online submission system for submitting manuscripts, revised manuscripts, response letters, supplementary files, and required forms.
All communication during peer review should take place through the journal’s official editorial system or official Editorial Office email.
pISSN: 2538-2330
eISSN: 2538-4600
Editor-in-Chief:
Seyed Mohammad Javad Mortazavi, MD.
Deputy Editors:
Mohammad Hossein Nabian, MD.
Amir Reza Farhoud, MD.

![]() |
All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |